Abstract
Highly variable levels of amylase, amylase inhibitor, trypsin inhibitor, and lectin activities were found in 10 randomly selected brands of starch blockers. This variability was attributed to the crude nature of the legume protein concentrate used in the formulation of these tablets. In addition to the possible risk to health associated with their trypsin inhibitor and lectin content, the levels of endogenous amylase activity present in such tablets may serve to counteract their alleged effectiveness as inhibitors of starch digestion.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
